Comparación entre el tratamiento con dexametasona y metilprednisolona en pacientes hospitalizados por COVID-19

Zárate Gaona, Diana Estela; Sobarzo Narvaez, Patricia María; Ibáñez, Fátima Alma; Núñez, Fátima; Peralta Giménez, Ruth María; Gómez, Lilian Leticia; Torres, Margaret; Benítez Duarte, Paola Elizabeth; Dávalos Ortiz, José Carlos; Ávalos, Domingo Santiago; Ferreira Samudio, María Leticia; Coronel Díaz, Geovana.
Rev. virtual Soc. Parag. Med. Int ; 9(2)sept. 2022.
Artículo en Español | LILACS-Express | ID: biblio-1410072

Documentos relacionados

  1. Real-world effectiveness of steroids in severe COVID-19: a retrospective cohort study.
  2. A Comparison of the Efficacy of Adjuvant Parenteral Methylprednisolone and Dexamethasone in Reducing Covid-19 Disease Severity and Mortality among the Moderate to Critical Patients -A Retrospective Study.
  3. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
  4. High-dose pulse methylprednisolone vs. dexamethasone standard therapy for severe and critical COVID-19 pneumonia: Efficacy assessment in a retrospective single-centre experience from Malaysia.
  5. Comparison of Clinical Outcome between Dexamethasone and Methyl Prednisolone in Treatment of Moderate to Severe COVID-19: A Systematic Review and Meta-Analysis.
  6. [Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia].
  7. Effect of pulse methylprednisolone on prognosis in SARS-CoV-2 patients with severe pneumonia.
  8. Efficacy of different doses of corticosteroids in treating severe COVID-19 pneumonia.
  9. Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.
  10. Treatment with 3-day methylprednisolone pulses in severe cases of COVID-19 compared with the standard regimen protocol of dexamethasone.